Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Fritz Offner

Show Sort by

Add to list
- Conference Paper
- C3
Long-term clinical outcomes and correlative efficacy analyses in patients (pts) with relapsed/refractory follicular lymphoma (r/r FL) treated with tisagenlecleucel in the ELARA trial

Martin Dreyling, Michael Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P. Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio Chavez, Emmanuel Bachy, Koji Kato, et al.

(2022) BLOOD. In Blood 140(Supplement 1). p.1459-1463
Add to list
- Conference Paper
- C3
Intravenous and subcutaneous administration of RG6234, a novel GPRC5DxCD3 T-cell engaging bispecific antibody, is highly active in patients with relapsed/refractory multiple myeloma (RRMM) : biomarker results from a phase I study

Iryna Dekhtiarenko, Iva Lelios, Jan Attig, Nassim Sleiman, Domenico Lazzaro, Emilie Schindler, Jan Eckmann, Pablo Umana, Wolfgang Jacob, Meike Schneider, et al.

(2022) BLOOD. In Blood 140(Supplement 1). p.10137-10139
Add to list
- Conference Paper
- C3
RG6234, a GPRC5DxCD3 T-cell engaging bispecific antibody, is highly active in patients (pts) with relapsed/refractory multiple myeloma (RRMM) : updated intravenous (IV) and first subcutaneous (SC) results from a phase I dose-escalation study

Carmelo Carlo-Stella, Rita Mazza, Salomon Manier, Thierry Facon, Sung-Soo Yoon, Youngil Koh, Simon J. Harrison, Jeremy Er, Antonio Pinto, Francesco Volzone, et al.

(2022) BLOOD. In Blood 140(Supplement 1). p.397-399
Add to list
- Miscellaneous
- open access
Many people with chronic lymphocytic leukemia or small lymphocytic lymphoma benefit from Ibrutinib treatment up to 8 years : a plain language summary

Paul M. Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan A. Burger, Peter Hillmen, Claire Dearden, Sebastian Grosicki, Helen McCarthy, et al.

(2022) FUTURE ONCOLOGY. 18(37). p.4047-4057
Add to list
- Conference Paper
- C3
CD8 presence and dynamics in glofitamab-treated patients with relapsed/refractory B-cell Non-Hodgkin lymphoma using the CD8-specific PET tracer Zr-89-crefmirlimab berdoxam

Martin Hutchings, Annika Loft, Wendy Osborne, George Petrides, Fritz Offner (UGent) , Ciel De Vriendt (UGent) , Giuseppe Gritti, Roberto Boni, William Townsend, Irfan Kayani, et al.

(2022) BLOOD. In Blood 140(Supplement 1). p.10733-10735
Add to list
- Journal Article
- A1
- open access
Combining Ixazomib with subcutaneous rituximab and dexamethasone in relapsed or refractory Waldenstrom's macroglobulinemia : final analysis of the phase I/II HOVON124/ECWM-R2 study

Marie Jose Kersten, Karima Amaador, Monique C. Minnema, Josephine M. I. Vos, Kazem Nasserinejad, Marcel Kap, Efstathios Kastritis, Maria Gavriatopoulou, Willem Kraan, Martine E. D. Chamuleau, et al.

(2022) JOURNAL OF CLINICAL ONCOLOGY. 40(1). p.40-52
Add to list
- Conference Paper
- C3
First-line treatment (Tx) with subcutaneous (SC) epcoritamab (epco) plus R-CHOP in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL) : phase 1/2 data update

Lorenzo Falchi, Fritz Offner (UGent) , David Belada, Joshua Brody, Kim M. Linton, Yasmin Karimi, Raul Cordoba, Sylvia Snauwaert, Aqeel Abbas, Liwei Wang, et al.

(2022) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 40(16, Supplement).
Add to list
- Conference Paper
- C3
Glofitamab in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and >= 2 prior therapies : pivotal phase II expansion results

Michael Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wrobel, Fritz Offner (UGent) , Marek Trneny, et al.

(2022) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 40(16, Supplement).
Add to list
- Conference Paper
- C3
Subcutaneous epcoritamab plus R-DHAX/C in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) eligible for autologous stem cell transplant (ASCT) : preliminary phase 1/2 results

Pau Abrisqueta, Lorenzo Falchi, Tycel Jovelle Phillips, Sven De Vos, Marcel Nijland, Fritz Offner (UGent) , Irina Bykhovski, Jun Wu, Liwei Wang, Ali Rana, et al.

(2022) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 40(16).
Add to list
- Journal Article
- A1
- open access
Inhibition of the protein arginine methyltransferase PRMT5 in high-risk multiple myeloma as a novel treatment approach

Philip Vlummens (UGent) , Stefaan Verhulst, Kim De Veirman, Anke Maes, Eline Menu, Jerome Moreaux, Hugues De Boussac, Nicolas Robert, Elke De Bruyne (UGent) , Dirk Hose, et al.

(2022) FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 10.

← Previous

1
…
3
4
5
6
…
35

Next →